Effectiveness of Testosterone Undecanoate Treatment in Men with Asthenospermia

Bo SONG,Zhi-ming CAI

DOI: https://doi.org/10.1016/s1001-7844(13)60014-0

2012-01-01

Abstract:To assess the effectiveness of testosterone undecanoate on sperm motility and pregnancy incidence in men with asthenospermia. A clinical trial was performed. Fifty men with asthenospermia were included to receive placebo (control group, n=9) or T undecanoate 80 mg/d (study group, n=41). Pregnancy incidence and sperm characteristics after 1, 2 and 3 months of medication and 3 months after the end of the trial were measured. Compared with the placebo, T undecanoate treatment produced a satisfactory improvement of seminal motility (F=55.904, P=0.000). In study group, the incidence of pregnancy was 28.2% while the incidence of pregnancy in control group was 11.1%. In study group, 26 patients took T undecanoate for more than 3 months. In the 3 months, semen volume showed no statistical difference (F=1.206, P=0.312) before and after treatment, sperm concentration (F=0.023, P=0.000) and motility a, b, a+b (P=0.000) showed statistical differences. Motility grade a showed significantly higher increment in 2 and 3 months after treatment than 1 month and there was no statistical difference between 2 and 3 months. So did grade b. The results indicate that T undecanoate increases seminal motility, leading to a higher incidence of pregnancy in couples with infertility related to asthenoaspermia.